She Yun, Zhu Lingling, Guo Xiangyun, Qin Jinran, Zhou Xiqiao, Yu Jiangyi, Yan Qianhua
Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China.
The First Clinical Medical College of Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
BMJ Public Health. 2025 Mar 13;3(1):e001447. doi: 10.1136/bmjph-2024-001447. eCollection 2025 Jan.
Given the absence of specific pharmacological treatments for sarcopenia, identifying effective lifestyle and dietary interventions is imperative. This study aims to explore the association between the composite dietary antioxidant index (CDAI) and sarcopenia, offering new insights into nutritional strategies for sarcopenia-prone populations.
This cross-sectional study analysed secondary data from the National Health and Nutrition Examination Survey cycles spanning 2001-2006 and 2011-2018. Weighted multivariate logistic regression and restricted cubic spline (RCS) analyses were employed to evaluate the non-linear association between CDAI and sarcopenia and to perform stratified analyses.
In this study, encompassing 19 683 American adults, representative of the national population of 132 140 502 residents, 7.97% were diagnosed with sarcopenia. Across all adjusted models, a higher CDAI was inversely associated with the risk of sarcopenia (OR 0.94, 95% CI 0.92, 0.96; <0.0001). The highest quartile of CDAI scores to those in the lowest revealed significantly reduced odds of sarcopenia (OR 0.46, 95% CI 0.38, 0.56; <0.0001). RCS analysis demonstrated a non-linear relationship between CDAI and sarcopenia. Additionally, stratified analyses indicated that the inverse association between CDAI and sarcopenia was more pronounced among participants with higher educational levels and those diagnosed with tumours.
There was a negative relationship between CDAI scores and the prevalence of sarcopenia, suggesting that higher CDAI scores may help in managing and preventing the occurrence of sarcopenia.
鉴于目前尚无针对肌肉减少症的特异性药物治疗方法,确定有效的生活方式和饮食干预措施势在必行。本研究旨在探讨复合饮食抗氧化指数(CDAI)与肌肉减少症之间的关联,为易患肌肉减少症的人群提供营养策略的新见解。
本横断面研究分析了2001 - 2006年和2011 - 2018年国家健康与营养检查调查周期的二手数据。采用加权多因素逻辑回归和受限立方样条(RCS)分析来评估CDAI与肌肉减少症之间的非线性关联并进行分层分析。
本研究纳入了19683名美国成年人,代表了全国132140502名居民的人口,其中7.97%被诊断为肌肉减少症。在所有调整模型中,较高的CDAI与肌肉减少症风险呈负相关(比值比[OR]为0.94,95%置信区间[CI]为0.92,0.96;P<0.0001)。CDAI得分最高四分位数者与最低四分位数者相比,肌肉减少症的患病几率显著降低(OR为0.46,95%CI为0.38,0.56;P<0.0001)。RCS分析表明CDAI与肌肉减少症之间存在非线性关系。此外,分层分析表明,CDAI与肌肉减少症之间的负相关在教育程度较高的参与者和被诊断患有肿瘤的参与者中更为明显。
CDAI得分与肌肉减少症患病率之间存在负相关关系,表明较高的CDAI得分可能有助于管理和预防肌肉减少症的发生。